Concepedia

Jill Slater

JS

Statistics

Publications

3

Citations

36

H-Index

3

Active since

2013

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Jill Slater is an author at GlaxoSmithKline (United Kingdom) specializing in clinical pharmacology, pharmacology, and antiviral pharmacotherapy.

Publications per year

2013–2021

3

Publications

3

Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir

Mindy Magee, Jill Slater, Frank Mannino et al. · The Journal of Clinical Pharmacology · 2020 · 13 citations

, , +17

Dolutegravir-based regimens in treatment-naive and treatment-experienced aging populations: analyses of 6 phase III clinical trials

Frank Spinelli, Manyu Prakash, Jill Slater et al. · HIV Research & Clinical Practice · 2021 · 13 citations · Full text

, , +17

Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease History or Cardiovascular Risk Factors: Results of a Pooled Analysis of Phase 3 Clinical Trials

W. James Cook, Brian Bryzinski, Jill Slater et al. · Postgraduate Medicine · 2013 · 10 citations

, , +17

1–3 of 3